Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Nanogen patents

Patents where

Current Assignee

Name

Nanogen

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7527939 Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP	Patent 7527939 was granted and assigned to Nanogen on May, 2009 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7527939	May 5, 2009
‌ US Patent 7172864 Methods for electronically-controlled enzymatic reactions	Patent 7172864 was granted and assigned to Nanogen on February, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7172864	February 6, 2007
‌ US Patent 7314708 Method and apparatus for electronic synthesis of molecular structures	Patent 7314708 was granted and assigned to Nanogen on January, 2008 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7314708	January 1, 2008
‌ US Patent 7425308 Systems for the active electronic control of biological reactions	Patent 7425308 was granted and assigned to Nanogen on September, 2008 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7425308	September 16, 2008
‌ US Patent 7172896 Integrated portable biological detection system	Patent 7172896 was granted and assigned to Nanogen on February, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7172896	February 6, 2007
‌ US Patent 7150997 Multiplexed active biologic array	Patent 7150997 was granted and assigned to Nanogen on December, 2006 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7150997	December 19, 2006
‌ US Patent 7597932 Mesoporous permeation layers for use on active electronic matrix devices	Patent 7597932 was granted and assigned to Nanogen on October, 2009 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7597932	October 6, 2009
‌ US Patent 7122327 Biopolymer markers indicative of type II diabetes	Patent 7122327 was granted and assigned to Nanogen on October, 2006 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7122327	October 17, 2006
‌ US Patent 7179610 Complement C3 precursor biopolymer markers indicative of insulin resistance	Patent 7179610 was granted and assigned to Nanogen on February, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7179610	February 20, 2007
‌ US Patent 7314762 Apolipoprotein biopolymer markers indicative of insulin resistance	Patent 7314762 was granted and assigned to Nanogen on January, 2008 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7314762	January 1, 2008
‌ US Patent 7135297 Protein biopolymer markers indicative of insulin resistance	Patent 7135297 was granted and assigned to Nanogen on November, 2006 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7135297	November 14, 2006
‌ US Patent 7601301 Multiplexed active biologic array	Patent 7601301 was granted and assigned to Nanogen on October, 2009 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7601301	October 13, 2009
‌ US Patent RE39816 Conjunctive analysis of biological marker expression for predicting cardiac mortality	Patent RE39816 was granted and assigned to Nanogen on September, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	RE39816	September 4, 2007
‌ US Patent 7267751 Programmable multiplexed active biologic array	Patent 7267751 was granted and assigned to Nanogen on September, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7267751	September 11, 2007
‌ US Patent 7601493 Methods and apparatus for screening and detecting multiple genetic mutations	Patent 7601493 was granted and assigned to Nanogen on October, 2009 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7601493	October 13, 2009
‌ US Patent 7314717 Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons	Patent 7314717 was granted and assigned to Nanogen on January, 2008 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7314717	January 1, 2008
‌ US Patent 7135283 Topoisomerase type II gene polymorphisms and their use in identifying drug resistance and pathogenic strains of microorganisms	Patent 7135283 was granted and assigned to Nanogen on November, 2006 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7135283	November 14, 2006
‌ US Patent 7314542 Methods and materials for optimization of electronic transportation and hybridization reactions	Patent 7314542 was granted and assigned to Nanogen on January, 2008 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7314542	January 1, 2008
‌ US Patent 7241419 Circuits for the control of output current in an electronic device for performing active biological operations	Patent 7241419 was granted and assigned to Nanogen on July, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7241419	July 10, 2007
‌ US Patent 7101661 Apparatus for active programmable matrix devices	Patent 7101661 was granted and assigned to Nanogen on September, 2006 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7101661	September 5, 2006
‌ US Patent 7125678 Protein biopolymer markers predictive of type II diabetes	Patent 7125678 was granted and assigned to Nanogen on October, 2006 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7125678	October 24, 2006
‌ US Patent 7101717 Addressable biologic electrode array	Patent 7101717 was granted and assigned to Nanogen on September, 2006 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7101717	September 5, 2006
‌ US Patent 7582421 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip	Patent 7582421 was granted and assigned to Nanogen on September, 2009 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7582421	September 1, 2009
‌ US Patent 7294688 Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons	Patent 7294688 was granted and assigned to Nanogen on November, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7294688	November 13, 2007
‌ US Patent 7256053 Diagnostic device for analyte detection	Patent 7256053 was granted and assigned to Nanogen on August, 2007 by the United States Patent and Trademark Office.	Nanogen	United States Patent and Trademark Office	7256053	August 14, 2007

Results per page:

30 results

0 selected

30 results

0 selected